ophthalmologytimes17h
FDA grants rare paediatric disease designation for retinitis pigmentosa gene therapy candidate VG901 from ViGeneron
ViGeneron GmbH, a clinical-stage gene therapy company based in Munich, Germany, shared details of two new milestones in an ...
ophthalmologytimes13h
Heidelberg Engineering announces FDA clearance for ANTERION Epithelial Thickness Module, Ectasia View
The Epithelial Thickness Module is expected to be commercially available in February 2025. According to Heidelberg ...